candesartan cilexetil has been researched along with Focal Segmental Glomerulosclerosis in 5 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with candesartan cilexetil lowered systemic blood pressure, normalized PGC at 10 weeks and greatly reduced proteinuria and allograft glomerulosclerosis at 24 weeks." | 3.69 | Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats. ( Azuma, H; Brenner, BM; Mackenzie, HS; Nagano, H; Rennke, HG; Tilney, NL; Troy, JL; Ziai, F, 1997) |
| "In vehicle-treated rats, proteinuria, glomerulosclerosis, interstitial mononuclear cell (MNC) infiltration and interstitial fibrosis developed." | 1.30 | Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. ( Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, A | 1 |
| Kim, S | 1 |
| Wanibuchi, H | 1 |
| Iwao, H | 1 |
| Noda, M | 1 |
| Fukuda, R | 1 |
| Matsuo, T | 2 |
| Ohta, M | 2 |
| Nagano, H | 2 |
| Imura, Y | 2 |
| Nishikawa, K | 1 |
| Shibouta, Y | 2 |
| Obata, J | 1 |
| Nakamura, T | 1 |
| Kuroyanagi, R | 1 |
| Yoshida, Y | 1 |
| Guo, DF | 1 |
| Inagami, T | 1 |
| Mackenzie, HS | 1 |
| Ziai, F | 1 |
| Azuma, H | 1 |
| Troy, JL | 1 |
| Rennke, HG | 1 |
| Tilney, NL | 1 |
| Brenner, BM | 1 |
| Ishikawa, E | 1 |
| Ishimura, Y | 1 |
| Sugiyama, Y | 1 |
5 other studies available for candesartan cilexetil and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Angiotensin II and calcium blockers prevent glomerular phenotypic changes in remnant kidney model.
Topics: Actins; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biomarke | 1996 |
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 1997 |
Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; | 1997 |
Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 1997 |
Renal protective effect of candesartan cilexetil in spontaneously hypercholesterolemic rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Be | 2002 |